首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Neoplasia

缩写:NEOPLASIA

ISSN:1476-5586

e-ISSN:1476-5586

IF/分区:7.7/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引2192
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Meagan B Myers,Malathi Banda,Karen L McKim et al. Meagan B Myers et al.
Mutant cancer subpopulations have the potential to derail durable patient responses to molecularly targeted cancer therapeutics, yet the prevalence and size of such subpopulations are largely unexplored. We employed the sensitive and quanti...
Bin Luo,Minggang Wang,Nengyi Hou et al. Bin Luo et al.
Helicobacter pylori infection is the strongest risk factor for development of gastric cancer. Host cellular stress responses, including inflammatory and immune responses, have been reported highly linked to H. pylori-induced carcinogenesis....
Kana Kobayashi,Hajime Yano,Akihiro Umakoshi et al. Kana Kobayashi et al.
CD200 induces immunosuppression in myeloid cells expressing its receptor CD200R, which may have consequences for tumor immunity. We found that human carcinoma tissues express not only full-length CD200 (CD200L) but also its truncated form, ...
Veronica Ortega,Alka Chaubey,Christina Mendiola et al. Veronica Ortega et al.
Genomic instability is a well-known hallmark of cancer. Recent genome sequencing studies have led to the identification of novel phenomena called chromothripsis and chromoanasynthesis in which complex genomic rearrangements are thought to b...
Felix Y Feng,Yu Zhang,Vishal Kothari et al. Felix Y Feng et al.
Purpose: Increased murine double minute 2 (MDM2) expression, independent of p53 status, is associated with increased cancer-specific mortality for men with prostate cancer treated with radiotherapy. We assessed MI-219, a ...
Chi-Wei Chen,Ming-Hsi Wu,Yi-Fan Chen et al. Chi-Wei Chen et al.
The therapeutic effect in non-small cell lung cancer (NSCLC) patients is limited because of intrinsic and acquired resistance. Thus, an unmet need exists for the development of new drugs to improve the therapeutic efficacy in NSCLC patients...
Jessica Tilghman,Paula Schiapparelli,Bachuchu Lal et al. Jessica Tilghman et al.
Glioblastoma (GBM) stem cells (GSCs) represent tumor-propagating cells with stem-like characteristics (stemness) that contribute disproportionately to GBM drug resistance and tumor recurrence. Understanding the mechanisms supporting GSC ste...
Yiannis Drosos,Geoffrey Neale,Jianming Ye et al. Yiannis Drosos et al.
The current paradigm of pancreatic neoplastic transformation proposes an initial step whereby acinar cells convert into acinar-to-ductal metaplasias, followed by progression of these lesions into neoplasias under sustained oncogenic activit...
Xuyuan Dong,Ester Fernandez-Salas,Enxiao Li et al. Xuyuan Dong et al.
Crizotinib is the first anaplastic lymphoma kinase (ALK) inhibitor to have been approved for the treatment of non-small cell lung cancer (NSCLC) harboring an ALK fusion gene, but it has been found that, in the clinic, patients develop resis...
Sofia Halin Bergström,Stina H Rudolfsson,Anders Bergh Sofia Halin Bergström
Prostate cancer generally metastasizes to bone, and most patients have tumor cells in their bone marrow already at diagnosis. Tumor cells at the metastatic site may therefore progress in parallel with those in the primary tumor. Androgen de...